David L. Fitzgerald

Array ( [id] => 3591894 [patent_doc_number] => 05487976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-30 [patent_title] => 'DNA encoding an insect gamma-aminobutyric acid (GABA) receptor subunit cells expressing it, and pesticide screening methods using such cells' [patent_app_type] => 1 [patent_app_number] => 8/137614 [patent_app_country] => US [patent_app_date] => 1993-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13382 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/487/05487976.pdf [firstpage_image] =>[orig_patent_app_number] => 137614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456875 [patent_doc_number] => 05472867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-05 [patent_title] => 'Ex vivo expansion of peripheral blood progenitor cells' [patent_app_type] => 1 [patent_app_number] => 8/128884 [patent_app_country] => US [patent_app_date] => 1993-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3678 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/472/05472867.pdf [firstpage_image] =>[orig_patent_app_number] => 128884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3005810 [patent_doc_number] => 05354664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-11 [patent_title] => 'DNA encoding a human thrombomodulin having a modified glycosaminoglycan (GAG) binding site' [patent_app_type] => 1 [patent_app_number] => 8/110011 [patent_app_country] => US [patent_app_date] => 1993-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7182 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/354/05354664.pdf [firstpage_image] =>[orig_patent_app_number] => 110011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3551673 [patent_doc_number] => 05492825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-20 [patent_title] => 'Mammalian inward rectifier potassium channel cDNA, IRK1, corresponding vectors, and transformed cells' [patent_app_type] => 1 [patent_app_number] => 8/103445 [patent_app_country] => US [patent_app_date] => 1993-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 41 [patent_no_of_words] => 18721 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/492/05492825.pdf [firstpage_image] =>[orig_patent_app_number] => 103445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3423111 [patent_doc_number] => 05459051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-17 [patent_title] => 'Methods and vectors for over-expression of ubiquitin fusion proteins in host cells' [patent_app_type] => 1 [patent_app_number] => 8/101506 [patent_app_country] => US [patent_app_date] => 1993-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4367 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/459/05459051.pdf [firstpage_image] =>[orig_patent_app_number] => 101506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2993191 [patent_doc_number] => 05362631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-08 [patent_title] => 'C-myb transfected T98G cells which produce GM-CSF and stem cell factor' [patent_app_type] => 1 [patent_app_number] => 8/099868 [patent_app_country] => US [patent_app_date] => 1993-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 6425 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/362/05362631.pdf [firstpage_image] =>[orig_patent_app_number] => 099868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3418114 [patent_doc_number] => 05453492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-26 [patent_title] => '60 kDa transforming growth factor-.beta.-binding protein and its use to detect or purify TGF-.beta.' [patent_app_type] => 1 [patent_app_number] => 8/098647 [patent_app_country] => US [patent_app_date] => 1993-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 8291 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/453/05453492.pdf [firstpage_image] =>[orig_patent_app_number] => 098647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883048 [patent_doc_number] => 05776725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Recombinant production of glucagon receptors' [patent_app_type] => 1 [patent_app_number] => 8/086631 [patent_app_country] => US [patent_app_date] => 1993-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28344 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776725.pdf [firstpage_image] =>[orig_patent_app_number] => 086631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3556042 [patent_doc_number] => 05501962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same' [patent_app_type] => 1 [patent_app_number] => 8/081539 [patent_app_country] => US [patent_app_date] => 1993-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30680 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/501/05501962.pdf [firstpage_image] =>[orig_patent_app_number] => 081539 [rel_patent_id] =>[rel_patent_doc_number] =>)